Stability analysis of Rift Valley fever transmission model with efficient and cost-effective interventions
- PMID: 40269025
- PMCID: PMC12019165
- DOI: 10.1038/s41598-025-98722-5
Stability analysis of Rift Valley fever transmission model with efficient and cost-effective interventions
Abstract
Rift Valley fever (RVF) is one of the neglected tropical diseases in Africa, likely to spread to other countries outside the continent, and capable of wreaking havoc on livestock and human populations. This study presents a novel mathematical model for RVF, taking into account time-dependent treatment, vaccination, and environmental sanitation controls. The existence of both RVF-free (disease-free) and RVF-present (endemic) equilibrium points are established analytically. Using the center manifold theory, the co-existence of both equilibrium points is characterized via bifurcation analysis. Castillo-Chavez's M-matrix approach and Lyapunov function are used to carry out the global stability analysis of the model around the disease-free and endemic equilibrium points, respectively. Furthermore, existence of triple optimal control is rigorously proved and characterized using Pontryagin's maximum principle. Consequently, the most efficient and cost-effective of each of the controls and several combinations of the controls are investigated through efficiency and cost-effectiveness analyses. The findings of the study provide insights into long term behavior of the RVF dynamics in the population, suggesting efficient prevention and optimal control measures at minimal cost of intervention.
Keywords: Bifurcation analysis; Economic analysis; Global stability; Mathematical model; Optimal control; Rift Valley fever.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Figures





Similar articles
-
Estimation of Rift Valley fever virus spillover to humans during the Mayotte 2018-2019 epidemic.Proc Natl Acad Sci U S A. 2020 Sep 29;117(39):24567-24574. doi: 10.1073/pnas.2004468117. Epub 2020 Sep 14. Proc Natl Acad Sci U S A. 2020. PMID: 32929025 Free PMC article.
-
Modelling the persistence and control of Rift Valley fever virus in a spatially heterogeneous landscape.Nat Commun. 2021 Sep 22;12(1):5593. doi: 10.1038/s41467-021-25833-8. Nat Commun. 2021. PMID: 34552082 Free PMC article.
-
Stability, bifurcation and chaos analysis of vector-borne disease model with application to Rift Valley fever.PLoS One. 2014 Oct 1;9(10):e108172. doi: 10.1371/journal.pone.0108172. eCollection 2014. PLoS One. 2014. PMID: 25271641 Free PMC article.
-
Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.Expert Rev Vaccines. 2017 Jun;16(6):601-611. doi: 10.1080/14760584.2017.1321482. Epub 2017 May 2. Expert Rev Vaccines. 2017. PMID: 28425834 Free PMC article. Review.
-
Rift Valley Fever.Clin Lab Med. 2017 Jun;37(2):285-301. doi: 10.1016/j.cll.2017.01.004. Epub 2017 Mar 22. Clin Lab Med. 2017. PMID: 28457351 Free PMC article. Review.
References
-
- Centers for Disease Control and Prevention (CDC). Rift valley fever. U.S. Department of Health and Human Services, https://www.cdc.gov/vhf/rvf/index.html (2020). Accessed: March 11, 2025.
-
- World Health Organization (WHO). Rift valley fever, https://www.who.int/health-topics/rift-valley-fever (2023). Accessed: March 11, 2025.
-
- Bird, B. H., Ksiazek, T. G., Nichol, S. T. & MacLachlan, N. J. Rift valley fever virus. J. Am. Vet. Med. Assoc.234, 883–893 (2009). - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources